Kate Kelland

HIV numbers hit new high as AIDS drugs save lives

LONDON (Reuters) - More people than ever are living with the AIDS virus but this is largely due to better access to drugs that keep HIV patients alive and well for many years, the United Nations AIDS program (UNAIDS) said on Monday.
 

HIV numbers hit new high as AIDS drugs save lives

LONDON (Reuters) - More people than ever are living with the AIDS virus but this is largely due to better access to drugs that keep HIV patients alive and well for many years, the United Nations AIDS program (UNAIDS) said on Monday.
 

Life-saving AIDS drugs push HIV numbers to new high

LONDON (Reuters) - More people than ever are living with the AIDS virus but this is largely due to better access to drugs that keep HIV patients alive and well for many years, the United Nations AIDS programme (UNAIDS) said on Monday.
 

Phone therapy and exercise can ease chronic pain

LONDON (Reuters) - Patients with chronic and widespread pain who got a course of a talking treatment called cognitive behavioral therapy (CBT) on the phone reported feeling "better" or "very much better" after 6 months, the results of study showed Monday.
 

Low levels of radioactive particles in Europe: IAEA

VIENNA (Reuters) - Very low levels of radioactive iodine-131 have been detected in Europe but the particles are not believed to pose a public health risk, the U.N. nuclear agency said Friday, saying it was seeking to find the source.
 

Brain analysis can help predict psychosis: study

LONDON (Reuters) - Computer analysis of brain scans could help predict how serious or long term a psychotic patient's illness may become and help doctors make more accurate decisions about how best to treat them, researchers said on Monday.
 

Adding radiotherapy boosts prostate cancer survival

LONDON (Reuters) - Adding radiotherapy to hormone drugs for prostate cancer patients significantly improves survival compared with hormone treatment alone, and the combination could save many lives if it were made standard practice, scientists said Thursday.
 

Top UK court backs patent linked to HGS, GSK drug

LONDON (Reuters) - Britain's highest court upheld a patent on Wednesday on a gene sequence held by Human Genome Sciences related to its new lupus drug Benlysta, in a defeat for rival drugmaker Eli Lilly.
 

Speeding universe work wins Nobel

STOCKHOLM (Reuters) - The "astounding" discovery that the expansion of the universe is speeding up won the Nobel physics prize on Tuesday for three astronomers whose observations of exploding stars transformed our view of the world, and of how it may end.
 

Speeding universe work wins Nobel

STOCKHOLM (Reuters) - The "astounding" discovery that the expansion of the universe is speeding up won the Nobel physics prize on Tuesday for three astronomers whose observations of exploding stars transformed our view of the world, and of how it may end.
 

Faster expanding universe work wins physics Nobel

STOCKHOLM (Reuters) - The "astounding" discovery that the expansion of the universe is speeding up won the Nobel physics prize on Tuesday for three astronomers whose observations of exploding stars transformed our view of the world, and of how it may end.
 

Doctors' support for MMR key to halting measles in EU

LONDON (Reuters) - With almost 30,000 cases of measles and eight deaths from the disease recorded in the European Union so far this year, a leading health official is urging doctors to do more to ensure parents have their children vaccinated with MMR.
 

Bayer drug a "major new player" in prostate cancer

STOCKHOLM (Reuters) - An experimental drug from Germany's Bayer and Norwegian biotech Algeta that prolongs the lives of patients with advanced prostate cancer is a major step forward in treatment of the disease, cancer experts said on Saturday.
 

Tailored breast cancer drugs in focus at cancer meet

ZURICH (Reuters) - Doctors and investors at a cancer conference starting on Friday will be keen to find out more on the effectiveness of two promising new breast cancer drugs from Swiss drugmakers Roche and Novartis.
 

Serotonin levels affect brain's response to anger: study

LONDON (Reuters) - Fluctuating levels of the brain chemical serotonin, often brought on when someone hasn't eaten or is stressed, affect brain regions that enable people to regulate anger, scientists said Thursday.
 

Dangerous TB spreading at alarming rate in Europe: WHO

LONDON (Reuters) - Multidrug-resistant and extensively drug-resistant forms of tuberculosis (TB) are spreading at an alarming rate in Europe and will kill thousands unless health authorities halt the pandemic, the World Health Organization(WHO) said on Wednesday.
 

Coils almost halve risk of cervical cancer: study

LONDON (Reuters) - Contrary to popular belief, coil contraceptive devices might actually protect women against developing cervical cancer even though they don't stop the infection that commonly leads to the disease, according to the results of an international study.
 

Blast at French nuclear site kills one, no leaks

MARCOULE, France (Reuters) - A worker was killed in an explosion at a French nuclear waste site on Monday, but officials said there was no radioactive leak and the authorities quickly declared the emergency over.
 

Scientists find gene that controls chronic pain

LONDON (Reuters) - British scientists have identified a gene responsible for regulating chronic pain, called HCN2, and say their discovery should help drug researchers in their search for more effective, targeted pain-killing medicines.
 

Weight Watchers works, scientific study finds

LONDON (Reuters) - Overweight patients told by their doctors to go to Weight Watchers lose around twice as much weight as people receiving standard weight loss care over 12 months, according to the findings of a study published on Thursday.